Search Results 1001-1010 of 16363 for pharmacogenetics
Here's a look back at 10 (of many) of Mayo Clinic's influential precision medicine research studies of 2023. 1. Mayo Clinic organoid study reveals possible key ...
Radiology Informatics: Bradley J. Erickson · Regenerative Neurobiology: Anthony J. Windebank · Regenerative Neurosurgery and Neuro-Oncology: Terry C. Burns ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
This was seen with the altered metabolic gene expression of one of the key microbes in the gut — Bacteroides thetaiotaomicron. Changes in microbial membership ...
About this study. The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial will determine whether systematically assessing ...
Latest videos on Cancer for Medical Professionals from Mayo Clinic.
About this study. This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, phase 2 study in ...
Researchers use artificial intelligence, clinical data to create prediction tool for primary sclerosing cholangitis featured · Mayo Clinic first to perform CAR T ...
The purpose of this study is to get a deep understanding of women's feelings about, and fertility decisions after egg freezing for fertility preservation.
Additionally, to perform RNA Sequencing and targeted metabolomics analysis to identify alterations in gene expression and metabolites associated with the NAD ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.